Key insights
- Goldman Sachs issued $6.5B in new debt. Keefe, Bruyette & Woods reiterated a Market Perform rating with a $1,000 target, while Argus raised its target to $1,066 citing capital markets revenue. GS noted a decline in US existing home sales due to weather and suggested shorting EUR/HUF. The debt issuance may slightly increase leverage, while analyst opinions offer mixed signals.
Goldman Sachs Group Inc. (NYSE:GS) announced Monday the issuance of $6.5 billion in new debt securities. According to a press release statement filed with the Securities and Exchange Commission, the company issued the following notes on Monday under its shelf registration statement:
The filing also listed several classes of Goldman Sachs securities registered on the New York Stock Exchange, including its common stock and various series of preferred and capital securities.
The exhibits filed with the report include legal opinions and consents related to the securities issuance. The filing was signed by Assistant Secretary Matthew E. Tropp.
All information is based on a press release statement included in the company’s SEC filing.
In other recent news, Goldman Sachs Group Inc. has experienced notable developments. The firm is facing the departure of two senior bankers from its Asia operations, with Dawei Huang and Samuel Thong set to leave after seven years. In terms of analyst perspectives, Keefe, Bruyette & Woods reiterated a Market Perform rating on Goldman Sachs stock, maintaining a price target of $1,000. Meanwhile, Argus raised its price target for the company’s shares to $1,066, citing a surge in capital markets revenue as a driving factor.
Goldman Sachs also made headlines with its analysis of U.S. existing home sales, which declined 3.6% in March, a sharper drop than the median forecast. The firm noted that the decline likely reflected the lagged effects of adverse weather conditions. Additionally, Goldman Sachs strategists recommended shorting the euro against the forint, as Hungary’s new leaders discuss joining the eurozone. These recent developments provide investors with insights into the company’s current positioning and market strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.